Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 11
2003 14
2004 18
2005 20
2006 35
2007 43
2008 61
2009 69
2010 88
2011 112
2012 132
2013 177
2014 199
2015 208
2016 228
2017 261
2018 306
2019 377
2020 351
2021 420
2022 448
2023 143
Text availability
Article attribute
Article type
Publication date

Search Results

3,306 results
Results by year
Filters applied: . Clear all
Page 1
CD177+ cells produce neutrophil extracellular traps that promote biliary atresia.
Zhang R, Su L, Fu M, Wang Z, Tan L, Chen H, Lin Z, Tong Y, Ma S, Ye R, Zhao Z, Wang Z, Chen W, Yu J, Zhong W, Zeng J, Liu F, Chai C, Guan X, Liu T, Liang J, Zhu Y, Gu X, Zhang Y, Lui VCH, Tam PKH, Lamb JR, Wen Z, Chen Y, Xia H. Zhang R, et al. Among authors: liu f. J Hepatol. 2022 Nov;77(5):1299-1310. doi: 10.1016/j.jhep.2022.06.015. Epub 2022 Jul 5. J Hepatol. 2022. PMID: 35803543 Free article.
Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study.
Shi Y, Chen G, Wang X, Liu Y, Wu L, Hao Y, Liu C, Zhu S, Zhang X, Li Y, Liu J, Cao L, Cheng Y, Zhao H, Zhang S, Zang A, Cui J, Feng J, Yang N, Liu F, Jiang Y, Gu C; FURLONG investigators. Shi Y, et al. Among authors: liu f. Lancet Respir Med. 2022 Nov;10(11):1019-1028. doi: 10.1016/S2213-2600(22)00168-0. Epub 2022 Jun 2. Lancet Respir Med. 2022. PMID: 35662408 Clinical Trial.
Editorial: Approaches That Foster a Pro-Regenerative Environment.
Gregory CA, Lee RH, Liu F, Alge D. Gregory CA, et al. Among authors: liu f. Front Bioeng Biotechnol. 2022 Mar 9;10:873375. doi: 10.3389/fbioe.2022.873375. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35372300 Free PMC article. No abstract available.
Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study.
Chen B, Zhong J, Li X, Pan F, Ding Y, Zhang Y, Chen H, Liu F, Zhang Z, Zhang L, Drozda R, Oliinyk O, Goh AH, Chen X, Sun X, Rubin DT, Sandborn WJ, Chen M. Chen B, et al. Among authors: liu f. Gastroenterology. 2022 Dec;163(6):1555-1568. doi: 10.1053/j.gastro.2022.08.007. Epub 2022 Aug 10. Gastroenterology. 2022. PMID: 35963369 Clinical Trial.
3,306 results